A smart brain biopsy needle for faster and safer neurosurgery has received $1 million from the Australian Government’s BioMedTech Horizons program, operated by MTPConnect.
Exploring the nooks and crannies of the body’s organs seems fodder for a sci-fi movie. Yet, an international team of researchers and engineers has made this a reality — and it’s set to change the way we see human diseases. Continue reading
Tiny structures called nanocages have the potential to revolutionise treatment of conditions like Parkinson’s and Alzheimer’s diseases.
Two researchers, seemingly worlds apart: one a nanoscientist, the other a neuroscientist. Born in different hemispheres with labs in different states, at the start of their game-changing collaboration 2 years ago, they felt they were speaking different languages.
A University of Adelaide study that will investigate the prediction of risk of long-term impairment and neurodegenerative disease development following traumatic brain injury has been awarded $1,987,160 from the Federal Government’s Medical Research Future Fund’s (MRFF). Continue reading
Cardiovascular disease – which kills one Australian every 12 minutes — is caused by a hardening of the arteries due to abnormal deposits of fat and cholesterol (known as plaque) in the inner lining of the artery; a process known as atherosclerosis. When plaque deposits rupture, this can cause heart attacks and stroke. But what if the plaque could be prevented from rupturing using microscopic nanoparticles? Continue reading
When a couple cannot conceive naturally, they often turn to in-vitro fertilisation. And that’s when the spectre of ‘aneuploidy’ arises — the risk that a fertilised embryo will have an abnormal number of chromosomes instead of the usual 46, triggering a range of congenital disorders, most of which result in miscarriage, stillbirth or death of the baby soon after birth. Continue reading
Dr Asma Khalid enjoys wearing silk dresses, and appreciates diamonds for their beauty —but she never expected both silk and diamonds to end up being the cornerstone of her work as a physicist. Yet they have opened up a whole new way to see deep in the body, sense infections on the skin and even deliver drugs in controlled amounts. Continue reading
Pain is one of the most complicated ailments to treat because the symptoms and severity are subjective and current medications are associated with a variety of problems including addiction and abuse. This makes it tough for doctors to accurately assess patient’s pain levels and prescribe the best pain management tool for the individual. The complex mechanisms underlying pain are the reason why researchers can take decades to develop new treatments. Continue reading
There are three main types of pain: nociceptive pain, the type we’re most familiar with, from bee stings and ankle strains to inflammatory arthritis. There’s neuropathic pain, arising from damage to the peripheral nervous system or the brain itself due to disease or injury. Then there are functional pain disorders arising from complex organic dysfunction, sometimes called ‘primary pain’, but most often just known as ‘other’. Continue reading
As one of the first members of the Centre for Nanoscale BioPhotonics, Professor Heike Ebendorff-Heidepriem’s work touches virtually every piece of research at the centre.
She develops the optical glass fibres, along with their crucial coatings, that deliver information about the environment they are designed to measure. Continue reading